Allergy Conjunctivitis Market 2024 – Size, Industry Share, Trends And Forecast To 2033 | Allergan PLC, AbbVie Inc., Ajanta Pharma Limited, Akron Operating Company LLC, Alcon Inc., Alembic Pharmaceuticals Ltd.

Overview and Scope
Allergy conjunctivitis is inflammation of the lining of the eye (conjunctiva) which is caused by an allergic reaction to substances like pollen or mold spores. Conjunctiva is the membrane or tissue that covers the inside of eyelids, as well as the white part of the eyeball. Symptoms of allergic conjunctivitis includes red, itchy, and watery eyes.

Sizing and Forecast
The allergy conjunctivitis market size has grown strongly in recent years. It will grow from $2.4 billion in 2023 to $2.54 billion in 2024 at a compound annual growth rate (CAGR) of 5.8%. The growth in the historic period can be attributed to increasing incidence of allergic conditions, advancements in research and development, changing lifestyles and environmental factors, expansion of patient awareness, collaborations and partnerships, healthcare infrastructure development..

The allergy conjunctivitis market size is expected to see strong growth in the next few years. It will grow to $3.2 billion in 2028 at a compound annual growth rate (CAGR) of 5.9%. The growth in the forecast period can be attributed to increasing global allergy burden, personalized medicine approaches, growing geriatric population, biotechnological innovations, expanding healthcare access in developing regions, regulatory support and approvals.. Major trends in the forecast period include integration of novel drug delivery technologies, emphasis on patient education and awareness, development of combination therapies, incorporation of artificial intelligence (ai) in diagnosis, rise in environmental allergen management solutions..

To access more details regarding this report, visit the link:
https://www.thebusinessresearchcompany.com/report/allergy-conjunctivitis-global-market-report

Segmentation & Regional Insights
The allergy conjunctivitis market covered in this report is segmented –
1) Allergy Conjunctivitis Market By Drug Class: Antihistamines and Mast Cell Stabilizers, Corticosteroids, Other Drug Classes
2) Allergy Conjunctivitis Market By Disease Type: Mild, Severe
3) Allergy Conjunctivitis Market By Distribution Channel: Hospital Pharmacies, Drug Stores and Retail Pharmacies, Online Pharmacies

Top Major Players

Allergan PLC

AbbVie Inc.

Ajanta Pharma Limited

Akron Operating Company LLC

Alcon Inc.

Alembic Pharmaceuticals Ltd.

North America was the largest region in the allergy conjunctivitis market share in 2023. The regions covered in the allergy conjunctivitis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Intrigued to explore the contents? Secure your hands-on sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=8806&type=smp

Major Driver Impacting Market Growth
The rise in exposure to air pollutants and chemicals is expected to boost the growth of the allergy conjunctivitis market going forward. Human eyes, one of the most sensitive parts of the human body, are constantly at risk due to ongoing exposure to the poisons in air pollution. Long-term exposure to airborne pollutants and chemicals causes a variety of eye issues, including allergic conjunctivitis, allergies, burning, watering, blurred vision, redness, itching, and persistent discomfort, requiring treatments. For instance, according to the United States Environmental Protection Agency (EPA), an independent executive agency of the United States federal government tasked with environmental protection matters, in the United States, around 67 million tons of pollutants were released into the atmosphere in 2021. Therefore, the rise in exposure to air pollutants and chemicals is driving the growth of the allergy conjunctivitis market.

Key Industry Players
Major companies operating in the allergy conjunctivitis market report are Allergan plc, AbbVie Inc., Ajanta Pharma Limited, Akron Operating Company LLC, Alcon Inc., Alembic Pharmaceuticals Ltd., Atopix Therapeutics Ltd., Auven Therapeutics Management LLLP, Bausch & Lomb, Cipla Ltd., Grevis Pharmaceutical Private Limited, Indoco Remedies Ltd., Jabs Biotech Pvt. Ltd., JAWA Pharmaceuticals Pvt. Ltd., Novartis AG, Ocular Therapeutix Inc., Santen Pharmaceutical Co. Ltd., Sun Pharmaceutical Industries Ltd., Laboratoires Thea SAS, Aciex Therapeutics Inc., Bausch Health Companies Inc., C.H. Boehringer Sohn AG & Co. KG, Eyevance Pharmaceuticals LLC, Johnson & Johnson Services Inc., Mylan N.V., Nicox S.A., Omeros Corporation, Otsuka Pharmaceutical Co. Ltd., Pfizer Inc., Regeneron Pharmaceuticals Inc., Shire plc, Teva Pharmaceutical Industries Ltd., Zydus Cadila

The allergy conjunctivitis market report table of contents includes:

1. Executive Summary

2. Allergy Conjunctivitis Market Characteristics

3. Allergy Conjunctivitis Market Trends And Strategies

4. Allergy Conjunctivitis Market – Macro Economic Scenario

5. Global Allergy Conjunctivitis Market Size and Growth

…..

32. Global Allergy Conjunctivitis Market Competitive Benchmarking

33. Global Allergy Conjunctivitis Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Allergy Conjunctivitis Market

35. Allergy Conjunctivitis Market Future Outlook and Potential Analysis

36. Appendix